Rare diseases
Investigational molecules
Locations
296 conditions with trials, the busiest first
580 trials across Europe, recruiting first
Study of V940 and Pembrolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer After Surgery
FranceStudy on Durvalumab with Trimodality Therapy for Patients with Muscle-Invasive Bladder Cancer
SpainStudy on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment
BelgiumStudy Comparing Erdafitinib with Vinflunine, Docetaxel, or Pembrolizumab for Patients with Advanced Urothelial Cancer and FGFR Gene Changes
BelgiumStudy on Continuing or Stopping Immunosuppressive Therapy with Rituximab in Patients with ANCA Vasculitis and End-stage Kidney Disease
FranceStudy Comparing Nivolumab and Cabozantinib with Sunitinib for Patients with Untreated Advanced Kidney Cancer
CzechiaStudy of Axitinib and Immune Checkpoint Inhibitors for Patients with Untreated Advanced or Metastatic Kidney Cancer
FranceStudy Comparing Sepiapterin and Sapropterin for Treating Phenylketonuria in Patients Aged 2 Years and Older
CzechiaStudy of Pembrolizumab and Epacadostat vs Standard Treatment for Patients with Advanced or Metastatic Kidney Cancer
SpainStudy on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease
BelgiumStudy on Stopping Solifenacin and Mirabegron for Children with Daytime Urinary Incontinence
DenmarkRemote Study on Empagliflozin and Finerenone for Reducing Kidney Issues in Type 2 Diabetes Patients
The NetherlandsThe therapies tested most often in Renal and urinary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
